QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-06 00:24 UTC · Public disclosure record

IQVTICKER

Iqvia Holdings Inc.

BULLISH stock

Congress has disclosed 9 buys and 16 sells of IQV (Iqvia Holdings Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

9
Buy
16
Sell
-7
Net
6
Active politicians

Round-trip watch Still on the books

Members who disclosed buying IQV and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Rohit Khanna 2025-09-29 $180.72 $267.33 +47.9% in profit

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
31.6
no sector median
how it's calculated
P/E = price ÷ earnings per share
$267.33 ÷ $8.46 = 31.6
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
6.62
no sector median
how it's calculated
P/B = price ÷ book value per share
$267.33 ÷ $40.41 = 6.62
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
17.21
no sector median
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($44.1B + $13.8B net debt) ÷ $3.4B = $57.9B ÷ $3.4B = 17.21
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

25 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Kevin Hern House SELL ◆ insider convergence · moderate Child · Gabrielle Ashtyn Hern Trust 2026-09-08 7 days +4.0% $1K–$15K
0.1% of NW
49.6 ↗ filing
Kevin Hern House SELL ◆ insider convergence · moderate Child · Hern Family Revocable Trust 2026-09-03 12 days -0.7% $1K–$15K
0.1% of NW
49.5 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence Child 2025-09-29 3 days +13.1% $1K–$15K 24.5 ↗ filing
Rob Bresnahan House SELL Self · JP Morgan Brokerage Account 2025-05-15 0 days 0.0% $1K–$15K
0.2% of NW
14.0 ↗ filing
Rob Bresnahan House BUY Self · JP Morgan Brokerage Account 2025-04-08 0 days 0.0% $15K–$50K
0.9% of NW
51.3 ↗ filing
Rob Bresnahan House SELL Self · JP Morgan Brokerage Account 2025-02-25 0 days 0.0% $1K–$15K
0.2% of NW
64.4 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence Child 2023-12-05 30 days — $1K–$15K 40.5 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence Child 2023-11-03 32 days — $1K–$15K 75.9 ↗ filing
Susie Lee House SELL ◆ insider convergence Joint · DSL Living Trust > Bank of New York Brokerage Account 340 2023-05-09 10 days — $1K–$15K
0.2% of NW
17.5 ↗ filing
Susie Lee House SELL ◆ insider convergence Joint · DSL Living Trust > Bank of New York Brokerage Account 340 2023-04-20 13 days — $1K–$15K
0.2% of NW
18.1 ↗ filing
Daniel Goldman House SELL ◆ insider convergence Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K 2023-04-10 23 days — $15K–$50K
<0.1% of NW
94.9 ↗ filing
Kevin Hern House SELL Child · Kelby Austin Hern Trust 2022-04-22 1 days — $1K–$15K
0.1% of NW
15.7 ↗ filing
Kevin Hern House BUY Joint 2021-09-02 1 days — $15K–$50K
0.4% of NW
48.0 ↗ filing
Kevin Hern House BUY Child 2021-05-20 1 days — $1K–$15K
0.1% of NW
40.5 ↗ filing
Kevin Hern House BUY Joint 2021-05-18 1 days — $100K–$250K
2.1% of NW
96.7 ↗ filing
Gilbert Cisneros House SELL Self 2020-11-04 40 days — $1K–$15K
0.1% of NW
10.6 ↗ filing
Gilbert Cisneros House SELL Self 2020-11-03 0 days — $15K–$50K
0.3% of NW
30.7 ↗ filing
Gilbert Cisneros House SELL Self 2020-09-24 19 days — $1K–$15K
0.1% of NW
22.3 ↗ filing
Gilbert Cisneros House SELL Self 2020-09-23 20 days — $1K–$15K
0.1% of NW
40.5 ↗ filing
Susie Lee House SELL Joint 2020-06-04 27 days — $1K–$15K
0.2% of NW
10.6 ↗ filing
Susie Lee House SELL Joint 2020-05-19 13 days — $1K–$15K
0.2% of NW
15.7 ↗ filing
Susie Lee House BUY Joint 2019-04-25 6 days — $1K–$15K
0.2% of NW
22.3 ↗ filing
Susie Lee House BUY Joint 2019-02-27 2 days — $1K–$15K
0.2% of NW
40.5 ↗ filing
Gilbert Cisneros House SELL Self 2019-02-05 30 days — $1K–$15K
0.1% of NW
86.9 ↗ filing
Susie Lee House SELL Joint 2019-01-29 0 days — $1K–$15K
0.2% of NW
86.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in IQV — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

5
Congress trades with insider convergence
3
…with insider divergence
43
Insider open-market trades

Of the congressional trades in IQV, 5 coincided with corporate insiders moving the same way within 60 days, and 3 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-09-02 Berkshire James G. Other SELL $697K ↗ EDGAR
2026-08-03 STAUB W RICHARD Other SELL $1.3M ↗ EDGAR
2026-07-31 Patel Bhavik Other SELL $436K ↗ EDGAR
2026-07-29 BOUSBIB ARI Director SELL $1.1M ↗ EDGAR
2026-07-29 BOUSBIB ARI Director SELL $1.1M ↗ EDGAR
2026-07-29 BOUSBIB ARI Director SELL $10.8M ↗ EDGAR
2026-07-29 BOUSBIB ARI Director SELL $13.0M ↗ EDGAR
2026-07-29 Cherofsky Keriann Other SELL $137K ↗ EDGAR
2026-07-29 Sherbet Eric Other SELL $1.2M ↗ EDGAR
2025-12-18 BOUSBIB ARI Director SELL $8.1M ↗ EDGAR
2025-10-29 BOUSBIB ARI Director SELL $174K ↗ EDGAR
2025-10-29 BOUSBIB ARI Director SELL $1.6M ↗ EDGAR
2025-10-29 BOUSBIB ARI Director SELL $3.0M ↗ EDGAR
2025-10-29 BOUSBIB ARI Director SELL $1.0M ↗ EDGAR
2025-10-29 BOUSBIB ARI Director SELL $5.8M ↗ EDGAR
2025-10-29 BOUSBIB ARI Director SELL $882K ↗ EDGAR
2025-10-29 Sherbet Eric Other SELL $879K ↗ EDGAR
2025-07-23 Sherbet Eric Other SELL $1.1M ↗ EDGAR
2025-07-23 Cherofsky Keriann Other SELL $105K ↗ EDGAR
2024-12-03 DANHAKL JOHN G Director BUY $256K ↗ EDGAR
2024-08-27 Sherbet Eric Other SELL $320K ↗ EDGAR
2024-03-01 BOUSBIB ARI Director SELL $4.1M ↗ EDGAR
2024-03-01 BOUSBIB ARI Director SELL $3.9M ↗ EDGAR
2024-02-29 STAUB W RICHARD Other SELL $2.2M ↗ EDGAR
2024-02-29 STAUB W RICHARD Other SELL $760K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
Congress 2026-09-08 Kevin Hern SELL $1K–$15K
Congress 2026-09-03 Kevin Hern SELL $1K–$15K
◆ insider 2026-09-02 Berkshire James G. Other SELL $697K
◆ insider 2026-08-03 STAUB W RICHARD Other SELL $1.3M
◆ insider 2026-07-31 Patel Bhavik Other SELL $436K
◆ insider 2026-07-29 BOUSBIB ARI Director SELL $1.1M
◆ insider 2026-07-29 BOUSBIB ARI Director SELL $1.1M
◆ insider 2026-07-29 BOUSBIB ARI Director SELL $10.8M
◆ insider 2026-07-29 BOUSBIB ARI Director SELL $13.0M
◆ insider 2026-07-29 Cherofsky Keriann Other SELL $137K
◆ insider 2026-07-29 Sherbet Eric Other SELL $1.2M
◆ insider 2025-12-18 BOUSBIB ARI Director SELL $8.1M
◆ insider 2025-10-29 BOUSBIB ARI Director SELL $174K
◆ insider 2025-10-29 BOUSBIB ARI Director SELL $1.6M
◆ insider 2025-10-29 BOUSBIB ARI Director SELL $3.0M
◆ insider 2025-10-29 BOUSBIB ARI Director SELL $1.0M
◆ insider 2025-10-29 BOUSBIB ARI Director SELL $5.8M
◆ insider 2025-10-29 BOUSBIB ARI Director SELL $882K
◆ insider 2025-10-29 Sherbet Eric Other SELL $879K
Congress 2025-09-29 Rohit Khanna BUY $1K–$15K
◆ insider 2025-07-23 Sherbet Eric Other SELL $1.1M
◆ insider 2025-07-23 Cherofsky Keriann Other SELL $105K
Congress 2025-05-15 Rob Bresnahan SELL $1K–$15K
Congress 2025-04-08 Rob Bresnahan BUY $15K–$50K

FAQ Common questions

How much has Congress traded IQV?

9 disclosed buys and 16 sells of IQV (Iqvia Holdings Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade IQV?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.